文献速递胃肠动力与功能性疾病

无胆汁酸吸收不良的腹泻型肠易激综合征患者的结肠传输与胆汁酸合成或排泄

Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
PubMed 文献 · Clin Gastroenterol Hepatol · 2016-11-14

在明尼苏达州社区招募的116例无显性胆汁酸吸收不良的腹泻型肠易激综合征患者中,总粪便胆汁酸、初级胆汁酸和分泌性胆汁酸与24小时和48小时结肠几何中心及粪便重量呈正相关,提示这些胆汁酸参与腹泻症状和结肠传输加速。

要点

  • 无显性胆汁酸吸收不良的腹泻型肠易激综合征患者中,粪便总胆汁酸、初级和分泌性胆汁酸与结肠传输加速相关。
  • 粪便总胆汁酸和血清C4正常或轻度升高的患者,其粪便初级胆汁酸比例高于健康对照。
  • 正常和轻度升高的粪便总胆汁酸水平对48小时结肠传输影响最大。

核心结论

  • 在无显性胆汁酸吸收不良的情况下,粪便中的总胆汁酸、初级胆汁酸和分泌性胆汁酸参与腹泻型肠易激综合征患者腹泻的结肠传输加速和粪便重量增加。

研究设计与样本

  • 横断面观察性研究,从明尼苏达州当地社区招募116例腹泻型肠易激综合征患者,并以30名健康志愿者作为对照。

主要发现

  • 粪便总胆汁酸水平低于2337 μmol/48小时(n=86)或血清C4水平低于47.1 ng/mL(n=91)的无显性胆汁酸吸收不良患者,其粪便总胆汁酸、初级胆汁酸和分泌性胆汁酸及粪便重量与24小时和48小时结肠几何中心呈显著正相关(P < .0036)。
  • 粪便总胆汁酸排泄或胆汁酸合成增加或正常的腹泻型肠易激综合征患者,其粪便初级胆汁酸(尤其是鹅脱氧胆酸)比例高于健康对照。

关键数值与推荐

  • 粪便总胆汁酸低于2337 μmol/48小时(n=86)或血清C4低于47.1 ng/mL(n=91)被定义为无显性胆汁酸吸收不良。
  • 采用Spearman相关检验研究假设,并对14项相关性检验进行校正(P < .0036)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Bile acids (BAs) are passively absorbed to a different extent along the mammalian colon, so that levels are lower in the feces than in proximal colon. Our aim was to explore associations among total, primary, and secretory BA in stool and colonic transit in patients with irritable bowel syndrome-diarrhea (IBS-D) without overt BA malabsorption (BAM). METHODS: In a cross-sectional observational study of 116 patients with IBS-D recruited from local communities in Minnesota, we measured total and individual main fecal BA excretion, fecal fat and fecal weight over 48 hours, fasting serum levels of C4 (surrogate for BA synthesis), and overall colonic transit by scintigraphy (geometric center at 24 hours and 48 hours). Patients without overt BAM were assigned to groups based on total fecal BA level below 2337 μmol/48 hours (n = 86) or serum levels of C4 below 47.1 ng/mL (n = 91). We used Spearman correlations to test study hypotheses with correction for 14 correlations tested (P < .0036). Data from 30 healthy volunteers were used as control subjects. RESULTS: Patients with IBS-D who had increased or normal total BA excretion in stool or BA synthesis had higher stool proportions of primary BAs (especially chenodeoxycholate), compared with healthy control subjects. In patients with IBS-D without overt BAM (normal 48-hour total fecal BA or serum C4), there were significant positive correlations between total fecal BA, fecal primary and secretory BA, fecal weight, and increased geometric center at 24 and 48 hours (P < .0036). Normal and slightly increased levels of total fecal BA have greatest effects on colonic transit at 48 hours. CONCLUSIONS: In the absence of overt BAM, the total, primary, and secretory BAs in stool contribute to the acceleration of colonic transit and fecal weight in the diarrhea of patients with IBS-D.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Peleman C, Camilleri M, Busciglio I, et al. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption. Clin Gastroenterol Hepatol. 2016. PMID: 27856362. doi:10.1016/j.cgh.2016.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。